Here we describe the X-ray crystal structure of a double-Trp mutant (Gly46→Trp/Gly262→Trp) of the lactose permease of Escherichia coli (LacY) with a bound, high-affinity lactose analog. Although thought to be arrested in an open-outward conformation, the structure is almost occluded and is partially open to the periplasmic side; the cytoplasmic side is tightly sealed. Surprisingly, the opening on the periplasmic side is sufficiently narrow that sugar cannot get in or out of the binding site. Clearly defined density for a bound sugar is observed at the apex of the almost occluded cavity in the middle of the protein, and the side chains shown to ligate the galactopyranoside strongly confirm more than two decades of biochemical and spectroscopic findings. Comparison of the current structure with a previous structure of LacY with a covalently bound inactivator suggests that the galactopyranoside must be fully ligated to induce an occluded conformation. We conclude that protonated LacY binds D-galactopyranosides specifically, inducing an occluded state that can open to either side of the membrane.
Here we describe the X-ray crystal structure of a double-Trp mutant (Gly46→Trp/Gly262→Trp) of the lactose permease of Escherichia coli (LacY) with a bound, high-affinity lactose analog. Although thought to be arrested in an open-outward conformation, the structure is almost occluded and is partially open to the periplasmic side; the cytoplasmic side is tightly sealed. Surprisingly, the opening on the periplasmic side is sufficiently narrow that sugar cannot get in or out of the binding site. Clearly defined density for a bound sugar is observed at the apex of the almost occluded cavity in the middle of the protein, and the side chains shown to ligate the galactopyranoside strongly confirm more than two decades of biochemical and spectroscopic findings. Comparison of the current structure with a previous structure of LacY with a covalently bound inactivator suggests that the galactopyranoside must be fully ligated to induce an occluded conformation. We conclude that protonated LacY binds D-galactopyranosides specifically, inducing an occluded state that can open to either side of the membrane.
X-ray structure | membrane protein | transport | conformational change | induced fit T he lactose permease of Escherichia coli (LacY), a paradigm for the major facilitator superfamily (MFS), binds and catalyzes transport of D-galactose and D-galactopyranosides specifically with an H + (1, 2). In contrast, LacY does not recognize D-glucose or D-glucopyranosides, which differ only in the orientation of the C4-OH of the pyranosyl ring. By using the free energy released from the energetically downhill movement of H + in response to the electrochemical H + gradient (Δμ H +), LacY catalyzes the uphill (active) transport of galactosides against a concentration gradient. Because coupling between sugar and H + translocation is obligatory, in the absence of Δμ H +, LacY also can transduce the energy released from the downhill transport of sugar to drive uphill H + transport with the generation of Δμ H +, the polarity of which depends upon the direction of the sugar gradient.
It also has been shown that LacY binds sugar with a pK a of ∼10.5 and that sugar binding does not induce a change in ambient pH; both findings indicate that the protein is protonated over the physiological range of pH (3) (4) (5) . These observations and many others (1, 2) provide evidence for an ordered kinetic mechanism in which protonation precedes galactoside binding on one side of the membrane and follows sugar dissociation on the other side. Recent considerations (6) suggest that a similar ordered mechanism may be common to other members of the MFS.
Because equilibrium exchange and counterflow are unaffected by imposition of Δμ H +, it is apparent that the alternating accessibility of sugar-and H + -binding sites to either side of the membrane is the result of sugar binding and dissociation and not of Δμ H + (reviewed in refs. 1 and 2). Moreover, downhill lactose/ H + symport from a high to a low lactose concentration exhibits a primary deuterium isotope effect that is not observed for Δμ H +-driven lactose/H + symport, equilibrium exchange, or counterflow (7, 8) . Thus, it is likely that the rate-limiting step for downhill symport is deprotonation (9, 10) , whereas in the presence of Δμ H + either dissociation of sugar or a conformational change leading to deprotonation is rate-limiting. X-ray crystal structures of WT LacY (11), the conformationally restricted mutant C154G (12, 13) , and a single-Cys mutant with covalently bound methanethiosulfonyl-galactopyranoside (MTSGal) (14) have been determined in an inward-facing conformation. The structures consist of two six-helix bundles that are related by a quasi twofold symmetry axis in the membrane plane, linked by a long cytoplasmic loop between helices VI and VII. Furthermore, in each six-helix bundle, there are two three-helix bundles with inverted symmetry (6, 15) . The two six-helix bundles surround a deep hydrophilic cavity tightly sealed on the periplasmic face and open only to the cytoplasmic side (an inward-open conformation). Although crystal structures reflect only a single lowest-energy conformation under conditions of crystallization, the entire backbone appears to be accessible to water (16) (17) (18) , and an abundance of biochemical and spectroscopic data (19) (20) (21) (22) (23) (24) (25) (26) (27) demonstrate that sugar binding causes the molecule to open alternatively to either side of the membrane, thereby providing strong evidence for an alternating-access model (reviewed in refs. 28 and 29) .
The initial X-ray structure of conformationally restricted C154G LacY was obtained with density at the apex of the central cavity, but because of limited resolution, the identity of the bound sugar at this site and/or side-chain interactions are difficult to specify with certainty. However, biochemical and spectroscopic studies show that LacY contains a single galactosidebinding site and that the residues involved in sugar binding are located at or near the apex of the central cavity. Although the specificity of LacY is strongly directed toward the C4-OH of the galactopyranosyl ring, other OH groups also are important in the following order: C4-OH >> C6-OH > C3-OH > C2-OH (30, 31) . Cys-scanning mutagenesis, site-directed alkylation, and direct binding assays show that Glu126 (helix IV) and Arg144
Significance
The lactose permease of Escherichia coli (LacY), a model for the major facilitator superfamily, catalyzes the symport of a galactopyranoside and an H + across the membrane by a mechanism in which the sugar-binding site in the middle of the protein becomes alternately accessible to either side of the membrane. However, all X-ray structures thus far show LacY in an inward-facing conformation with a tightly sealed periplasmic side. Significantly, by using a double-Trp mutant, we now describe an almost occluded, outward-open conformation with bound sugar, confirming more than two decades of biochemical and biophysical findings. We also present evidence that protonated LacY specifically binds D-galactopyranosides, inducing an occluded state that can open to either side of the membrane.
(helix V) are irreplaceable for substrate binding and probably are charge-paired (4, (32) (33) (34) (35) . Trp151 (helix V), two turns removed from Arg144, stacks aromatically with the galactopyranosyl ring (36, 37) . Glu269 (helix VIII), another irreplaceable residue (38) (39) (40) , also is essential for sugar recognition and binding and cannot be replaced even with Asp without markedly decreasing affinity (4, 41) . It has been shown recently (42) that Asn272 (helix VIII) also is essential for binding and transport. In contrast, Cys148 (helix V), which is protected from alkylation by substrate, and Ala122 (helix IV), where bulky replacements make LacY specific for galactose, are close to the binding site but probably do not contact the sugar directly.
Among the conserved residues in LacY and other MFS members are two Gly-Gly pairs between the N-and C-terminal six-helix bundles on the periplasmic side of LacY at the ends of helices II and XI (Gly46 and Gly370, respectively) and helices V and VIII (Gly159 and Gly262, respectively) (43) . When Gly46 (helix II) and Gly262 (helix VIII) are replaced with bulky Trp residues ( Fig. 1) , transport activity is abrogated with little or no effect on galactoside binding (44) . Moreover, site-directed alkylation and stopped-flow binding kinetics indicate that the G46W/ G262W mutant is open on the periplasmic side (open outward). In addition, the detergent-solubilized mutant exhibits much greater thermal stability than WT LacY (44) .
The G46W/G262W mutant now has been crystallized in the presence of a high-affinity lactose analog. Remarkably, the structure presented here depicts an almost occluded, outward-open conformation with a reliably defined model of the bound sugar molecule.
Results
Global Fold. An X-ray crystal structure of LacY G46W/G262W cocrystallized in the presence of 5 mM β-D-galactopyranosyl-1-thio-β-D-galactopyranoside (TDG) was determined to 3.5-Å resolution (Fig. 1) , and, importantly, crystals were not obtained in the absence of an added galactoside. Data collection and refinement statistics are summarized in SI Appendix, Table S1 . The protein crystallized in a different crystal form and space group than other LacY structures, suggesting an overall tertiary structure different from the previous inward-facing conformations (11) (12) (13) (14) . Crystals of the G46W/G262W mutant are in space group C222 1 with cell dimensions a = 101.6 Å, b = 121.9 Å, and c = 264.0 Å, and the structure was determined by molecular replacement using the partial structure of LacY (13) as the search molecule. The protein occupies 29% of the cell volume.
Two independent molecules in the asymmetric unit that are adjacent to one another, as if in a bilayer, but have oppositefacing orientations ( Fig. 1 and SI Appendix, Fig. S1 ). The Trp replacements on the periplasmic side are illustrated (SI Appendix, Fig. S2 ). Both molecules are in an almost occluded, outwardfacing conformation with a single molecule of TDG in the central sugar-binding site. However, the two structures (termed "A" and "B") differ slightly in the substrate orientation and in the arrangement of substrate-binding side chains, suggesting that they sample nearby states around the same part of the transport cycle. A space-filling view of molecule A from the periplasmic side ( Fig. 2A ) reveals bound TDG through an opening that is too narrow to allow entrance or exit (∼3 Å at the narrowest point) (45) . In contrast, the cytoplasmic side of the molecule is tightly sealed with residues Glu64 (helix II), Thr348 (helix XI), Tyr350 (helix XI), Phe334 (helix X), Phe140 (helix V), Gly141 (helix V), and Pro280 (helix VIII) providing a zipper-like motif (Fig. 2B) .
The overall rmsd between 380 Cαs of the mutant with bound TDG and WT LacY without any substrate bound [Protein Data Bank (PDB) ID code 2V8N] is 4.3 Å, consistent with very different states. Difference-distance analysis identifies two rigid bodies in these structures, one comprising most of the N-terminal helix bundle (168 residues) and the other comprising most of the Cterminal helix bundle (188 residues); the Cαs can be separately superimposed with rmsds of 1.2 Å. Thus, the mutant structure is related to WT apo LacY by an approximately 30°rotation of one rigid domain against the other about an axis perpendicular to the membrane plane. (Fig. 1 and SI Appendix, Fig. S3 ). Helix VI moves ∼12 Å closer to helix VII, and helix IV moves ∼12 Å closer to helix IX on the cytoplasmic side. The relative displacements of all helices are listed in SI Appendix, Tables S2 and S3 .
Substrate-Binding Site. The conformation of the high-affinity TDG molecule is clearly defined in the almost occluded central cavity (Figs. 1 and 3) and allows assignment of likely hydrogen-bond interactions with the protein (SI Appendix, Table S4 ), although the errors in interatomic distances are high at 3.5-Å resolution. Electron density for the sugar is seen in an omit map after refinement without TDG (SI Appendix, Fig. S4 ). The sugar is bound in a manner that is highly consistent with previous mutational, functional, and spectroscopic analyses (reviewed in refs. 1, 2, and 46).
One of the galactopyranosyl rings of TDG lies against Trp151 (helix V), confirming biochemical (36) and spectroscopic (37) findings that indicate hydrophobic stacking between the bottom of the galactopyranosyl ring and the indole ring of the aromatic Trp side chain (Fig. 4) . Although Trp151 can be replaced with Tyr or Phe, progressively decreased affinity is observed, and total replacement of the aromatic side chain at position 151 completely abolishes binding and transport. In addition, a red shift in the phosphorescence spectrum of single-Trp151 LacY observed upon sugar binding is explained by their apposition in the structure. Glu269 (helix VIII) is the acceptor of hydrogen bonds from the C4-OH group of the galactopyranosyl ring, making it a likely candidate for a primary role in specificity. The structure explains the finding that even conservative replacement with an Asp abolishes binding and inactivates transport (4, 39, 47) .
The η1 NH 2 group of Arg144 (helix V) donates a hydrogen bond to O5 in the ring and also is within hydrogen-bond distance of C6-OH. The η2 NH 2 group of Arg144 donates hydrogen bonds to C2′-OH of TDG and to Glu126 Oe2 (Fig. 4) . Conservative replacement of Arg144 with Lys or neutral replacements virtually destroys binding and transport (4, 32) .
Glu126 (helix IV) acts as hydrogen-bond acceptor from the C2′-OH of TDG, explaining why conservative replacement with Asp causes markedly diminished binding affinity and removal of the carboxyl group abolishes binding and transport (4, 33) .
His322 (helix X) acts as a hydrogen-bond donor/acceptor between the eNH of the imidazole ring and the C3-OH of TDG and is stabilized by a hydrogen-bond donor/acceptor with the δNH of the imidazole and the OH of Tyr236. All replacements for His322 tested exhibit a marked decrease in binding affinity and little or no transport activity (4, 48, 49) .
Finally, Asn272 (helix VIII) likely donates a hydrogen bond to the C4-OH of TDG, confirming the recent biochemical finding (42) indicating that Asn272 also plays an essential role in sugar binding. Gln is the only replacement that is well tolerated by LacY.
Additional Important Residues. In addition to the residues that play a direct role in galactoside binding, Cys148 (helix V), well known with respect to substrate protection against alkylation (reviewed in ref. 46) , is close to bound TDG but is not sufficiently close to interact directly. Similarly, replacement of Ala122 (helix IV) with bulky side chains or alkylation of A122C with bulky thiol reagents causes LacY to become specific for the monosaccharide galactose, and disaccharide binding and transport are blocked (50) . However, Ala122 does not make direct contact with TDG.
Asp240 (helix VII) and Lys-319 (helix X) are weakly salt bridged (51, 52) , and mutation of either residue does not markedly alter affinity (4).
Glu325 (helix X) and Arg302 (helix IX) (Figs. 4 and 6 ) are directly involved in coupled H + translocation. Neutral replacement of either residue yields mutants that are defective in all transport reactions that involve lactose/H + symport but catalyze equilibrium exchange and/or counterflow as well as or better than WT (1, 2). Neither residue is sufficiently close to the bound sugar to make direct contact.
Discussion
The G46W/G262W mutant of LacY described here behaves as if it is arrested in an outward-open conformation with diffusion-limited access to the binding site based on biochemical and spectroscopic measurements (44) . The X-ray crystal structure has bound substrate and as a result is almost occluded and still is partially open to the periplasmic side. Moreover, the opening is sufficiently narrow so that bound TDG is too bulky to exit from the binding site without concomitant and concerted structure changes, and the cytoplasmic side appears tightly sealed. A simple explanation is that, in the absence of sugar, the periplasmic pathway in the mutant is sufficiently open to allow access of TDG to the binding site. However, when binding occurs and the mutant attempts to transition into an occluded state, it cannot do so completely because the bulky Trp residues at positions 46 and 262 block complete closure. Thus, the mutant is able to bind sugar and can initiate but cannot complete the transition into an occluded state. Therefore, the mutant is completely unable to catalyze transport of any type across the membrane.
Although crystals of G46W/G262W diffract to 3.5 Å, the density observed in the cavity at the middle of the protein clearly defines the conformation of TDG, and no additives were present during crystallization that might give rise to artifactual densities. Furthermore, crystals of the mutant were obtained only in the presence of a galactopyranoside. It also is highly relevant that the amino acid side chains ligating the sugar in the structure are entirely consistent with extensive biochemical/spectroscopic studies. Finally, as shown in Figs. 5A and 6, which are from a study by Chaptal et al. (14) and show the structure of single-Cys122 LacY with covalently bound MTS-Gal, the galactosyl moiety of the inactivator exhibits precisely the same position in the binding site, as shown in Figs. 4 and 6 . In addition, two important ligands-Trp151 and Glu269-interact with the galactopyranosyl ring precisely as observed with TDG in the double-Trp mutant (Figs. 3, 4 , and 6). Fig. 3 . 2mFo-DFc electron density in a B-factor-sharpened map contoured at 1σ (green mesh) at the sugar-binding site of LacY G46W/G262W, molecule A. The density is superimposed on the structure, which is shown as sticks, with carbon atoms in gold, oxygen atoms in red, and nitrogen atoms in blue. Broken lines represent putative hydrogen bonds. Remarkably, as opposed to the almost occluded, open-outward conformation of TDG-bound G46W/G262W, LacY with covalently bound MTS-Gal in the binding site exhibits an inward-open conformation (Fig. 5B) . This difference clearly suggests that the sugar must be fully ligated to transition into the occluded state. Given this possibility and observations indicating that the alternating access mechanism of LacY is driven by galactoside binding and dissociation, and not by Δμ H +, it seems highly likely that sugar binding involves induced fit. By this means, the N-and C-terminal bundles converge as given side chains from both the N-and Cterminal helix bundles ligate the galactoside. The energetic cost of binding and the resultant conformational change are regained upon sugar dissociation and provide the energy for a further structural change that allows deprotonation. In brief, the mechanism of LacY resembles that of an enzyme, the difference being that the substrate-bound intermediate lies along a structural trajectory from one side to the other.
Another notable implication of the present structure is that Glu269, His322, and Tyr236, long considered by implication to be involved in coupled H + translocation (reviewed in refs. 1 and 2), are clearly ligands to the galactopyranoside. Although mutation of these residues causes the periplasmic side of LacY to open spontaneously (53), there is no direct evidence that they are involved in H + translocation, although it is conceivable that they may play a dual role in the transport mechanism.
In conclusion, it should be noted that the double-Gly motif observed in LacY that has led to the important and informative structure presented here is conserved in many members of the MFS (43) . Thus, the approach of using double-or even tetra-Trp substitutions in the double-Gly motifs may represent a general approach to obtaining structural information about other members of the MFS family, a particularly exciting possibility.
Methods
Materials. TDG was obtained from Carbosynth Limited. Buffers were from Sigma-Aldrich. Talon Superflow Resin was purchased from BD Clontech. Dodecyl-β-D-maltopyranoside (DDM) and n-nonyl-β-D-glucoside (NG) were obtained from Affymetrix. All other materials were of reagent grade and were obtained from commercial sources.
Growth, Expression, and Purification. Plasmid pT7-5 encoding LacY G46W/ G262W/His6 was expressed in E. coli C41. The detailed procedure is described in SI Appendix. Membranes were prepared and solubilized in DDM, and LacY was purified on a Co(II) column and eluted in 20 mM Hepes/0.2% NG/200 mM imidazole (pH 6.5). Details are given in SI Appendix.
Crystallization, Data Collection, and Structure Determination. TDG was added (5 mM final concentration) to a protein solution [10 mg/mL in 20 mM Hepes (pH 6.5)/0.2% NG] before crystallization trials. Crystallization screens were set up using the hanging-drop vapor-diffusion method on a Mosquito Crystal Robot (TTP Labtech) in a 96-well plate with a drop ratio of 100 nL well solution:100 nL protein. Crystals appeared in 24 h and grew to 500 × 150 × 150 μm in 1 wk. Crystals were harvested after 7 d and screened for diffraction. Crystals were reproducible and appeared in wide range of PEG concentrations. They also appeared at different pHs and with different buffers. The best-diffracting crystals grew in 1.0 M NaCl/0.05 M Tris (pH 8.0)/24% PEG 600. No cryoprotectant was added before data collection.
Diffraction data were collected at the Lawrence Berkeley National Laboratory Advanced Light Source Beamline 8.3.1, at −170°C and at a wavelength of 1.115 Å. The highest-resolution crystals diffracted to 3.5 Å. Data were processed with either XDS (54) or HKL2000 (55) .
The structure was solved by molecular replacement in PHENIX (56) using LacY 2CFQ as the search model. Coot was used for density fitting (57) , and refinement was done with PHENIX (56) and Refmac from the CCP4 suite (58) . Hydrogens were included in riding positions. In the final cycles of refinement, translation, libration, screw-motion parameters (59) for a single group (the entire structure) were refined, and Ramachandran angles were restrained. SI Appendix, Table S1 shows data and refinement statistics. The MolProbity server (60) was used for structural validation leading to improvement. Difference-distance analysis was done using 
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Rapido (61), and rigid body motions were analyzed using the Dyndom server (62).
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Structure of Sugar-Bound LacY Supplementary information
Methods:
Growth and expression: Plasmid pT7-5 encoding LacY G46W/G262W/His6 was expressed in E. coli C41. Transformed cells (colonies from LB/Amp plates) were inoculated into 200 ml of LB/Amp (0.1 mg/ml ampicillin, final concentration) and grown overnight at 37°C on a shaker.
200 ml cultures were inoculated into 10 Litre fermenters, and when the OD 600 reached 1 (~6hrs after inoculation) 2 mM IPTG was added to induce. Purification: Thawed membrane suspensions (50 ml) were placed in a glass beaker in an ice bath with stirring. DDM powder (1 gram) was added to 50 ml of membrane suspension (2% DDM, final concentration), and stirring was continued on ice for 30 minutes. The sample was then filtered thru 5 µm and 2 µm filters to remove insoluble material. To the combined supernatants (50 ml), 2.7 ml of 4 M NaCl (200 mM, final concentration) and 0.9 ml of 300 mM imidazole (5 mM, final concentration) was added, and the pH was adjusted to pH 7.6 by addition of 0.5 M Na2HPO4 (pH 10). The extract was then loaded onto a Talon column (1.5 x 5 cm) that had been equilibrated with 50 mM NaP i /0.01% DDM/200 mM NaCl/5 mM imidazole (pH 7.6) (Column Buffer). Non-absorbed material was washed from the column with Column Buffer, followed by washing with 50 mM NaP i /0.01% DDM/200 mM NaCl/10 mM imidazole (pH 7.6) (Wash Buffer 2) and 50 mM NaP i /0.2% NG (pH 7.6) (Wash Buffer 3) to background UV absorption.
Purified protein was eluted from the column with 20mM Hepes (pH 6.5)/0.2% NG/200 mM imidazole). The protein was finally concentrated with Amicon Ultra centrifugal filters (50K MWCO) at 3500 rpm in a swinging bucket rotor to 0.2 -0.5 ml and diluted in 15 ml of 20 mM Hepes /0.2% NG (pH 6.5) and concentrated again to ~10 mg/ml. TM= Transmembrane Helix, in Parenthesis = residue number used for distance calculation. 
